Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC90521Ornipressin (acetate)CAS: 914453-98-8Purity: >98.00%
Un dérivé peptidique synthétique de la vasopressine.
- GC90529Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt)Purity: >95.00%
Un substrat peptidique pour PKC
- GC90554E70K (trifluoroacetate salt)Purity: >98.00%
Un inhibiteur peptidique de l'interaction CXCL8-GAG
- GC90603Tat-CIRP (trifluoroacetate salt)Purity: >95.00%
Un inhibiteur peptidique de l'interaction protéine-protéine MD-2-CIRP
- GC90700Dendrogenin ACAS: 1191043-85-2Purity: >95.00%
Un modulateur sélectif de LXR et un inhibiteur de ChEH.
- GC90779Shepherdin (trifluoroacetate salt)Purity: >90.00%
Un inhibiteur de l'interaction survivine-Hsp90.
- GC908402-Chloroadenosine-5'-O-diphosphate (sodium salt)CAS: 82927-78-4Purity: >95.00%
Un dérivé d'ADP.
- GC90893Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-89-5Purity: >95.00%
Un isomère de l'ADP-α-S
- GC90894Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-90-8Purity: >95.00%
Un isomère de l'ADP-α-S
- GC91042Tauro-Obeticholic Acid (sodium salt)CAS: 2278141-79-8Purity: >98.00%
Un métabolite actif de l'acide obéticholique.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC90483 | Magainin 1 (trifluoroacetate salt) | - | >95.00% | |
Un peptide cationique antimicrobien | ||||
| GC90490 | PMX-53 (trifluoroacetate salt) | 514814-99-4 | >95.00% | |
Un antagoniste du récepteur C5a | ||||
| GC90516 | VK-II-86 | 955371-84-3 | >90.00% | |
Un inhibiteur de SOICR | ||||
| GC90521 | Ornipressin (acetate) | 914453-98-8 | >98.00% | |
Un dérivé peptidique synthétique de la vasopressine. | ||||
| GC90526 | st-Ht31 (ammonium salt) | - | >98.00% | |
Un peptide stéaré perméable à la cellule. | ||||
| GC90529 | Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt) | - | >95.00% | |
Un substrat peptidique pour PKC | ||||
| GC90546 | MOG Peptide (human, bovine) (acetate) | - | >95.00% | |
Un peptide de gaine de myéline endogène | ||||
| GC90554 | E70K (trifluoroacetate salt) | - | >98.00% | |
Un inhibiteur peptidique de l'interaction CXCL8-GAG | ||||
| GC90603 | Tat-CIRP (trifluoroacetate salt) | - | >95.00% | |
Un inhibiteur peptidique de l'interaction protéine-protéine MD-2-CIRP | ||||
| GC90672 | L202 | 2170488-92-1 | >95.00% | |
Un lipide cationique ionisable | ||||
| GC90684 | Lipid 2,2(8,8) 4C CH3 | 2230647-30-8 | >95.00% | |
Un lipide cationique ionisable | ||||
| GC90697 | Docosahexaenoic Acid-d5 ethyl ester | 159146-01-7 | >99.00% | |
Non applicable | ||||
| GC90700 | Dendrogenin A | 1191043-85-2 | >95.00% | |
Un modulateur sélectif de LXR et un inhibiteur de ChEH. | ||||
| GC90750 | cKK-E15 | 1432494-71-7 | >95.00% | |
Un lipide cationique ionisable | ||||
| GC90772 | YK-009 | 2761458-86-8 | >95.00% | |
Un lipide cationique ionisable | ||||
| GC90779 | Shepherdin (trifluoroacetate salt) | - | >90.00% | |
Un inhibiteur de l'interaction survivine-Hsp90. | ||||
| GC90822 | LAU-0901 | 727358-25-0 | >95.00% | |
Un antagoniste du récepteur PAF | ||||
| GC90840 | 2-Chloroadenosine-5'-O-diphosphate (sodium salt) | 82927-78-4 | >95.00% | |
Un dérivé d'ADP. | ||||
| GC90893 | Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-89-5 | >95.00% | |
Un isomère de l'ADP-α-S | ||||
| GC90894 | Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-90-8 | >95.00% | |
Un isomère de l'ADP-α-S | ||||
| GC90929 | Trofinetide (acetate) | - | >95.00% | |
Une dérivée de Gly-Pro-Glu | ||||
| GC90993 | CL4F8-6 | 2766493-12-1 | >98.00% | |
Un lipide cationique ionisable | ||||
| GC91028 | L-K6L9 (trifluoroacetate salt) | - | >98.00% | |
Un peptide cytolytique | ||||
| GC91042 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | >98.00% | |
Un métabolite actif de l'acide obéticholique. | ||||